Inflammatory polyps in the colon form when the intestinal lining goes through repeated cycles of damage and healing. They are not cancerous growths. Instead, they develop as a byproduct of inflammation, where the body’s repair process overshoots and produces excess tissue that protrudes into the colon like small bumps or finger-like projections. These polyps are sometimes called pseudopolyps because, unlike true polyps, they don’t arise from abnormal cell growth.
How Inflammatory Polyps Form
The colon is lined with a thin layer of tissue called the mucosa. When this lining is damaged by prolonged or recurring inflammation, it ulcerates, meaning patches of tissue break down and leave raw, open areas. As the body heals those ulcers, new tissue grows to fill the gaps. If the inflammation keeps returning, this cycle of destruction and regrowth repeats over and over, and the regenerating tissue can pile up unevenly. The result is raised mounds of inflamed, overgrown tissue surrounded by areas where the lining has been worn flat or scarred.
Under a microscope, these polyps contain inflamed connective tissue, overactive glands, and sometimes smooth muscle cells that have migrated into the area. They lack the cellular changes seen in precancerous polyps, which is why they’re classified as non-neoplastic (not related to tumor growth).
Inflammatory Bowel Disease Is the Primary Cause
The most common reason people develop inflammatory polyps is inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn’s disease. Roughly 10 to 20% of people with IBD develop these polyps, though some estimates range as high as 74% depending on how the polyps are detected and how long the disease has been active.
Ulcerative colitis is the more frequent culprit. Because it causes continuous inflammation along the colon lining, the conditions for that repeated damage-and-repair cycle are especially ripe. Crohn’s disease can also produce inflammatory polyps, though it does so less often. In Crohn’s, the polyps tend to appear in areas where deep ulceration has occurred, and about two-thirds of reported giant inflammatory polyps have been found in Crohn’s patients rather than those with ulcerative colitis.
The longer and more severe the inflammation, the more likely polyps are to develop. Someone who has had poorly controlled IBD for a decade will have a higher chance of developing them than someone whose disease has been well managed from the start.
Causes Beyond IBD
While IBD accounts for most cases, inflammatory polyps can also develop after other types of colon injury. Any condition that damages the intestinal lining severely enough to trigger that same cycle of ulceration and regrowth can be responsible. Documented non-IBD causes include:
- Ischemic colitis: reduced blood flow to the colon that damages the lining
- Infections: including colonic tuberculosis and severe bacterial colitis
- Enema-induced colitis: chemical irritation from certain enema preparations
- Necrotizing enterocolitis: a serious inflammatory condition most commonly seen in premature infants
- Stercoral ulcers: pressure sores caused by hard, impacted stool pressing against the colon wall
These are uncommon causes, but they illustrate the underlying principle: inflammatory polyps are a response to tissue injury, not a disease in themselves. Whatever damages the colon lining badly enough and long enough can produce them.
What They Feel Like
Most inflammatory polyps cause no symptoms at all. Small polyps are typically discovered incidentally during a colonoscopy performed for another reason, such as IBD surveillance or routine screening. You wouldn’t know they were there.
Larger or more numerous polyps are a different story. When inflammatory polyps grow big (sometimes called giant inflammatory polyps), the most common symptom is abdominal pain, often localized to one area. Chronic iron-deficiency anemia from slow, ongoing blood loss is another hallmark. The surface of large polyps can ulcerate, creating a source of persistent low-grade bleeding that shows up as fatigue, pale skin, and low iron levels before you ever notice blood in your stool. The transverse colon, which runs horizontally across your upper abdomen, is the most common location for these larger polyps.
Complications From Large Polyps
In rare cases, giant inflammatory polyps can cause more serious problems. A large polyp or a cluster of polyps can partially or completely block the colon, leading to symptoms of bowel obstruction: severe cramping, bloating, inability to pass gas or stool, and vomiting. Other uncommon complications include intussusception (where part of the intestine telescopes into itself, pulled along by a large polyp) and protein-losing enteropathy, a condition where the inflamed tissue leaks protein from the bloodstream into the gut, leading to low protein levels, swelling, and fatigue.
These complications are the exception. The vast majority of inflammatory polyps remain small and clinically insignificant.
Are They a Cancer Risk?
Inflammatory polyps are generally considered benign. They are not precancerous in the way that adenomatous polyps are, and they do not follow the typical polyp-to-cancer progression. That said, the picture is more nuanced than a simple “no risk” answer.
Research has found that DNA extracted from inflammatory polyps in IBD patients sometimes carries mutations associated with early cancer development. One study identified mutations in 4 out of 30 polyp samples, and another found chromosomal abnormalities in over 21% of samples. These findings don’t mean the polyps themselves become cancerous, but they suggest the tissue environment around them is under enough stress to accumulate genetic damage. The polyps may serve as a marker of a colon that has been through significant inflammation, and that inflammation itself is a known risk factor for colorectal cancer in IBD.
For this reason, the presence of inflammatory polyps doesn’t change the fundamental recommendation for IBD patients, which is regular colonoscopic surveillance starting 8 to 10 years after symptoms first began. Surveillance intervals are tailored to individual risk factors, including the overall burden of inflammation someone has experienced over their lifetime. Advanced imaging techniques using dye sprays or specialized light filters help distinguish harmless inflammatory polyps from the rare dysplastic (precancerous) lesion that can look similar during a standard exam.
How Inflammatory Polyps Are Managed
Small, clearly benign inflammatory polyps usually don’t need to be removed. A gastroenterologist will biopsy them during colonoscopy to confirm what they are, and if the tissue shows only inflammation and normal glandular tissue, no further intervention is needed.
Removal becomes necessary when polyps are large enough to cause symptoms like bleeding or obstruction, or when their appearance during colonoscopy makes it difficult to rule out a precancerous lesion. In those cases, the polyps can often be removed during the colonoscopy itself. Very large or obstructing polyps occasionally require surgery to remove the affected segment of colon.
The most important part of managing inflammatory polyps is managing the underlying cause. For IBD patients, controlling inflammation reduces the likelihood of new polyps forming and lowers the overall risk of colon cancer. The polyps themselves are a signal that the colon has been through significant inflammatory stress, and that signal is worth paying attention to even though the polyps are benign.